Open AccessTo treat or not to treat: HER2 equivocal is the matter!
Author(s) -
Armando Orlandi,
Vincenzo Arena
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2017.08.34
Subject(s) - medicine , oncology , human epidermal growth factor receptor 2 , clinical oncology , fluorescence in situ hybridization , breast cancer , trastuzumab , retrospective cohort study , immunohistochemistry , adjuvant therapy , targeted therapy , cancer , biochemistry , chemistry , chromosome , gene